Drug Shortage Report for TEVA-COMBO STERINEBS

Last updated on 2025-04-04 History
Report ID 226939
Drug Identification Number 02272695
Brand name TEVA-COMBO STERINEBS
Common or Proper name IPRATROP SALB 0.5/2.5MG UDV
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) IPRATROPIUM BROMIDE SALBUTAMOL
Strength(s) 0.5MG 2.5MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 20 X 2.5ML
ATC code R03AL
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-05-02
Estimated end date 2025-03-31
Actual end date 2025-04-03
Shortage status Resolved
Updated date 2025-04-04
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-09-19 English Compare
v8 2024-06-27 French Compare
v7 2024-06-27 English Compare
v6 2024-06-20 French Compare
v5 2024-06-20 English Compare
v4 2024-05-16 French Compare
v3 2024-05-16 English Compare
v2 2024-05-03 French Compare
v1 2024-05-03 English Compare

Showing 21 to 29 of 29